Pfizer Plans to Launch Anti-Smoking Chantix in India by End of February

NEW DELHI - On the heels of a study showing one million people die yearly in India from smoking-related illness, Pfizer plans to launch its anti-smoking tablet Chantix (varenicline) by the end of the month, Pfizer India told PharmAsia News

More from Archive

More from Scrip